Skip to menu Skip to content Skip to footer
Professor Nikolas Haass
Professor

Nikolas Haass

Email: 
Phone: 
+61 7 344 37087

Overview

Background

I am a clinician scientist and academic leader with research in melanoma cell biology and experimental melanoma therapy. I received my degree in medicine from the University of Heidelberg, Germany (1990-1998). I graduated summa cum laude with a PhD in Cell Biology from the University of Heidelberg (1993-1999) and trained in clinical dermatology at the University of Hamburg, Germany (1999-2003). In 2003 I moved to Philadelphia, PA, to work as a post-doctoral fellow in Meenhard Herlyn’s lab at The Wistar Institute (2003-2007). From there I was recruited as an associate faculty member to the Centenary Institute/University of Sydney (2007-2013). In 2013 I commenced a position as Associate Professor for Cutaneous Oncology at University of Queensland Diamantina Institute (now Frazer Institute) and was promoted to full Professor in April 2016.

Availability

Professor Nikolas Haass is:
Available for supervision

Qualifications

  • Doctoral Diploma, Ruprecht Karls Universität Heidelberg

Research impacts

Using cutting-edge technology, including real-time cell cycle imaging in 3D culture and in vivo, my team studies the role of dynamic melanoma heterogeneity in melanomagenesis with the goal to develop novel therapeutic approaches by simultaneously targeting different tumor cell subpopulations. My laboratory and our team are in the unique position to combine sophisticated imaging and biosensor approaches with biochemical methods to provide unprecedented insight to the mechanisms of tumor heterogeneity, tumor-stroma interactions and cancer immunology.

My contribution to the field is best evidenced by 97 original papers and invited reviews in leading biomedical journals. Many of our papers have a large impact in the field (>7500 citations in total, and 19 papers cited >100 times each). The papers in Mol Cancer Ther (2006, cited >500x), Cancer Res (2007, cited 265x) and PNAS (2008, cited 1500x) were evaluated by Faculty 1000 Biology as recommended or exceptional, respectively.

Works

Search Professor Nikolas Haass’s works on UQ eSpace

218 works between 1996 and 2024

141 - 160 of 218 works

2012

Conference Publication

Sequential digital dermoscopic imaging and total body photography aid detection of primary melanoma in individuals at high risk: a prospective 5-year follow-up study

Moloney, F., Guitera, P., Coates, E., Haass, N., Ho, K., Khoury, R., Mann, G. and Menzies, S. (2012). Sequential digital dermoscopic imaging and total body photography aid detection of primary melanoma in individuals at high risk: a prospective 5-year follow-up study. 92nd Annual Meeting of the British-Association-of-Dermatologists, Birmingham England, Jul 03-05, 2012. WILEY-BLACKWELL. doi: 10.1111/j.1365-2133.2012.10976.x

Sequential digital dermoscopic imaging and total body photography aid detection of primary melanoma in individuals at high risk: a prospective 5-year follow-up study

2012

Conference Publication

The use of multi-photon microscopy as a tool for studying elastin and elastin-related disorders in human skin

Tong, P. L., Qin, J., Roediger, B., Lowe, P. M., Leecy, T., Mrass, P., Weninger, W. and Haass, N. K. (2012). The use of multi-photon microscopy as a tool for studying elastin and elastin-related disorders in human skin. WILEY-BLACKWELL.

The use of multi-photon microscopy as a tool for studying elastin and elastin-related disorders in human skin

2012

Conference Publication

Effect of the BH3 mimetic ABT-737 on human melanoma cells to apoptosis induced by selective BRAF inhibitors.

Hersey, Peter, Wroblewski, David, Mijatov, Branka, Zhang, Xu Dong and Haass, Nikolas (2012). Effect of the BH3 mimetic ABT-737 on human melanoma cells to apoptosis induced by selective BRAF inhibitors.. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. AMER SOC CLINICAL ONCOLOGY.

Effect of the BH3 mimetic ABT-737 on human melanoma cells to apoptosis induced by selective BRAF inhibitors.

2012

Conference Publication

Melanoma detection in high risk patients: A case series

Coates, E., Moloney, F. J., Guitera, P., Haass, N., Ho, K., Khoury, R., Mann, G. and Menzies, S. W. (2012). Melanoma detection in high risk patients: A case series. WILEY-BLACKWELL.

Melanoma detection in high risk patients: A case series

2012

Conference Publication

MITF-driven subcompartment-specific distribution of differentially cycling tumor cells in melanoma

Haass, N. K., Anfosso, A., Beaumont, K. A., Hill, D. S., Mrass, P., Kinjyo, I., Kanagawa, O. and Weninger, W. (2012). MITF-driven subcompartment-specific distribution of differentially cycling tumor cells in melanoma. 75th Annual Meeting of the Society-for-Investigative-Dermatology, Raleigh Nc, May 09-12, 2012. NATURE PUBLISHING GROUP.

MITF-driven subcompartment-specific distribution of differentially cycling tumor cells in melanoma

2012

Conference Publication

Observation of a five year high risk clinic for primary melanoma

Moloney, F. J., Guitera, P., Coates, E., Haass, N., Ho, K., Khoury, R., Mann, G. and Menzies, S. W. (2012). Observation of a five year high risk clinic for primary melanoma. WILEY-BLACKWELL.

Observation of a five year high risk clinic for primary melanoma

2012

Conference Publication

The subcompartment-specific distribution of differentially cycling tumor cells in melanoma is regulated by MITF

Haass, N. K., Anfosso, A., Beaumont, K. A., Hill, D. S., Mrass, P., Kinjyo, I., Kanagawa, O. and Weninger, W. (2012). The subcompartment-specific distribution of differentially cycling tumor cells in melanoma is regulated by MITF. 39th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Marburg Germany, Mar 01-03, 2012. WILEY-BLACKWELL.

The subcompartment-specific distribution of differentially cycling tumor cells in melanoma is regulated by MITF

2012

Conference Publication

Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells

Stehn, J. R., Haass, N. K., Bonello, T., Desouza, M., Kottyan, G., Treutlein, H., Zeng, J., Nascimento, P. R., Butler, T., Allanson, M., Fath, T., Hill, T. A., McCluskey, A., Schevzov, G., Palmer, S., Hardeman, E. C., Winlaw, D., Reeve, V. E., Dixon, I., Weninger, W., Cripe, T. P. and Gunning, P. (2012). Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells. 39th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Marburg Germany, Mar 01-03, 2012. WILEY-BLACKWELL.

Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells

2012

Conference Publication

The role(s) of the junction protein ZO-1 in malignant melanoma

Bohner, C., Pandjaitan, M. A., Haass, N. K., Zorn-Kruppa, M., Moll, I., von den Driesch, P., Schaider, H. and Brandner, J. M. (2012). The role(s) of the junction protein ZO-1 in malignant melanoma. 39th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Marburg Germany, Mar 01-03, 2012. WILEY-BLACKWELL.

The role(s) of the junction protein ZO-1 in malignant melanoma

2012

Journal Article

Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737

Lucas, Keryn M., Mohana-Kumaran, Nethia, Lau, Diana, Zhang, Xu Dong, Hersey, Peter, Huang, David C., Weninger, Wolfgang, Haass, Nikolas K. and Allen, John D. (2012). Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737. Clinical Cancer Research, 18 (3), 783-795. doi: 10.1158/1078-0432.CCR-11-1166

Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737

2012

Conference Publication

Meeting report from the 2011 international melanoma congress, Tampa, Florida

Smalley, Keiran S. M., Aplin, Andrew E., Flaherty, Keith T., Hoeller, Christoph, Bosserhoff, Anja K., Haass, Nikolas K., Bosenberg, Marcus, Ribas, Antoni, Barnhill, Raymond, Kudchadkar, Ragini and Messina, Jane L. (2012). Meeting report from the 2011 international melanoma congress, Tampa, Florida. Malden, MA, United States: Wiley-Blackwell Publishing. doi: 10.1111/j.1755-148X.2011.00943.x

Meeting report from the 2011 international melanoma congress, Tampa, Florida

2011

Conference Publication

Real-time cell cycle imaging: Melanomas are composed of differentially cycling tumor cells in a subcompartment-specific distribution

Haass, N. K., Anfosso, A., Kinjyo, I., Kanagawa, O. and Weninger, W. (2011). Real-time cell cycle imaging: Melanomas are composed of differentially cycling tumor cells in a subcompartment-specific distribution. Annual Meeting of the Society-for-Investigative-Dermatology, Phoenix Az, May 04-07, 2011. NATURE PUBLISHING GROUP.

Real-time cell cycle imaging: Melanomas are composed of differentially cycling tumor cells in a subcompartment-specific distribution

2011

Journal Article

Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010

Hersey, P., Smalley, K. S., Weeraratna, A., Bosenberg, M., Zhang, X. D., Haass, N. K., Paton, E., Mann, G., Scolyer, R. A. and Tüting, T. (2011). Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010. Pigment Cell and Melanoma Research, 24 (1), e1-e15. doi: 10.1111/j.1755-148X.2010.00811.x

Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010

2011

Conference Publication

Utilization of the auto fluorescent drug Rose Bengal as a novel approach for the investigation of drug effects within solid tumors in 3D culture and in vivo

Nascimento, P. R., Knuever, J., Weninger, W. and Haass, N. (2011). Utilization of the auto fluorescent drug Rose Bengal as a novel approach for the investigation of drug effects within solid tumors in 3D culture and in vivo. 38th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Tuebingen Germany, Feb 17-19, 2011. WILEY-BLACKWELL PUBLISHING, INC.

Utilization of the auto fluorescent drug Rose Bengal as a novel approach for the investigation of drug effects within solid tumors in 3D culture and in vivo

2011

Conference Publication

Differential expression of ZO-1 in melanoma and nevi and their tumor microenvironment - an indicator of malignancy

Bohner, C., Haass, N. K., Vidal-y-Sy, S., Moll, I., von den Driesch, P., Schaider, H. and Brandner, J. (2011). Differential expression of ZO-1 in melanoma and nevi and their tumor microenvironment - an indicator of malignancy. 38th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Tuebingen Germany, Feb 17-19, 2011. WILEY-BLACKWELL PUBLISHING, INC.

Differential expression of ZO-1 in melanoma and nevi and their tumor microenvironment - an indicator of malignancy

2011

Conference Publication

Real-time imaging of cell cycle progression in melanoma

Haass, N., Anfosso, A., Kinjyo, I., Kanagawa, O. and Weninger, W. (2011). Real-time imaging of cell cycle progression in melanoma. 38th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Tuebingen Germany, Feb 17-19, 2011. WILEY-BLACKWELL PUBLISHING, INC.

Real-time imaging of cell cycle progression in melanoma

2011

Book Chapter

Egretta schistacea: Kuestenreiher

Haass, N. K. and Bauer, H.-G. (2011). Egretta schistacea: Kuestenreiher. Nicht-Singvögel: Rheidae (Nandus) - Phoenicopteridae (Flamingos). (pp. 266-268) edited by Jochen Hölzinger and Hans-Günther Bauer. Stuttgart, Germany: Ulmer Eugen Verlag.

Egretta schistacea: Kuestenreiher

2011

Conference Publication

Different ZO-1 Localization in Melanoma, Nevi and their Tumor-Microenvironment - An Indicator of Malignancy

Bohner, C., Haass, N. K., Moll, I, von den Driesch, P., Schaider, H. and Brandner, J. M. (2011). Different ZO-1 Localization in Melanoma, Nevi and their Tumor-Microenvironment - An Indicator of Malignancy. 46. Tagung der Deutschen Dermatologischen Gesellschaft Vereinigung Deutschsprachiger Dermatologen e. V., Dresden, Germany, 30 March - 2 April 2011. Berlin, Germany: Wiley-Blackwell Verlag GmbH. doi: 10.1111/j.1610-0387.2011.07632.x

Different ZO-1 Localization in Melanoma, Nevi and their Tumor-Microenvironment - An Indicator of Malignancy

2011

Journal Article

Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay

McGowan, Eileen M., Alling, Nikki, Jackson, Elise A., Yagoub, Daniel, Haass, Nikolas K., Allen, John D. and Martinello-Wilks, Rosetta (2011). Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay. PLoS ONE, 6 (6) e20623, e20623.1-e20623.8. doi: 10.1371/journal.pone.0020623

Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay

2011

Book Chapter

Cell-cell and cell-matrix contacts in melanoma and the tumor microenvironment

Kuphal, Silke and Haass, Nikolas K. (2011). Cell-cell and cell-matrix contacts in melanoma and the tumor microenvironment. Melanoma Development: Molecular Biology, Genetics and Clinical Application. (pp. 181-215) edited by Anja Bosserhoff. Vienna, Austria: SpringerWienNewYork. doi: 10.1007/978-3-7091-0371-5

Cell-cell and cell-matrix contacts in melanoma and the tumor microenvironment

Funding

Past funding

  • 2023 - 2024
    Changing the melanoma tumour microenvironment to improve both targeted and immune therapy
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2022 - 2023
    Laser capture microdissection to empower cancer discoveries, improve diagnosis, treatment and outcomes in amyloidosis patients
    IPF Healthy - Medical Research
    Open grant
  • 2020 - 2023
    Mathematical models of 4D multicellular spheroids (ARC Discovery Project administered by Queensland University of Technology)
    Queensland University of Technology
    Open grant
  • 2019
    Improving Immune Checkpoint Therapy of Melanoma
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2019 - 2022
    Induction of endoplasmic reticulum stress to potentiate immunogenic cell death to improve melanoma therapy
    Cancer Council Queensland
    Open grant
  • 2018 - 2022
    Improving outcomes for patients with melanoma brain metastases using novel personalised and response-adapted treatment strategies (PARF Translation Research Innovation Award administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2017 - 2024
    ACRF Cancer Ultrastructure and Function Facility
    Australian Cancer Research Foundation
    Open grant
  • 2017 - 2019
    Melanoma environment and heterogeneity in therapy sensitivity and resistance - Haass
    Meehan Bequest
    Open grant
  • 2017 - 2018
    Personalized medicine for renal cell carcinoma patients: use of patient-derived tumors for 3-D cell culture and animal models
    UQ-Ochsner Seed Fund for Collaborative Research - MABS funds
    Open grant
  • 2016
    Epigenetic remodelling driving acquired permanent drug resistance in melanoma cells
    PA Research Foundation
    Open grant
  • 2015 - 2018
    Defining the role of Microphthalmia-associated Transcription Factor (MITF) in melanoma heterogeneity by real-time cell cycle imaging
    NHMRC Project Grant
    Open grant
  • 2015
    Next-generation cell analysis: Automated high-throughput 3D microscope and multimode microplate reader
    NHMRC Equipment Grant
    Open grant
  • 2014
    Purchase of low O2 incubator and Dissociator
    NHMRC Equipment Grant
    Open grant
  • 2013 - 2014
    Real-time Imaging of cell cycle progression in melanoma
    NHMRC Project Grant
    Open grant

Supervision

Availability

Professor Nikolas Haass is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Professor Nikolas Haass's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au